Human QSOX2/QSCN6L1/SOXN ORF/cDNA clone-Lentivirus plasmid (NM_181701.4)

Cat. No.: pGMLV001675
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days

Pre-made Human QSOX2/QSCN6L1/SOXN Lentiviral expression plasmid for QSOX2 lentivirus packaging, QSOX2 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.

Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.

pdf Datasheet
pdf MSDS
pdf Terms of Use
Target products collection

Go to QSOX2/QSCN6L1 products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

Purchase
Total Price: $1012.98
Shipping fee: Limited-time free
For payment issues, contact us.


Product Description

Catalog ID pGMLV001675
Gene Name QSOX2
Accession Number NM_181701.4
Gene ID 169714
Species Human
Product Type Lentivirus plasmid (overexpression)
Insert Length 2097 bp
Gene Alias QSCN6L1,SOXN
Fluorescent Reporter ZsGreen
Mammalian Cell Selection Puromyocin
Fusion Tag 3xflag (C-Terminal)
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGGCGGCGGCCGGGGCGGCGGTGGCGCGCAGCCCGGGAATCGGAGCGGGACCTGCGCTGAGAGCCCGGCGCTCGCCCCCGCCGCGGGCCGCACGGCTGCCGCGGCTGCTAGTGCTGCTAGCGGCGGCGGCGGTGGGGCCGGGCGCGGGCGGTGCGGCGCGGCTGTACCGCGCGGGCGAGGACGCCGTGTGGGTGCTGGACAGCGGCAGCGTGCGCGGGGCCACCGCCAACAGCTCGGCCGCGTGGCTCGTGCAGTTCTACTCGTCGTGGTGTGGCCACTGCATCGGCTACGCGCCCACTTGGCGGGCCCTGGCTGGGGATGTGCGAGACTGGGCCAGTGCCATTCGCGTCGCAGCTCTGGACTGCATGGAAGAGAAGAACCAGGCCGTGTGCCATGACTACGACATCCACTTCTACCCCACCTTCCGGTATTTTAAAGCATTTACAAAGGAGTTTACAACTGGAGAAAATTTTAAAGGACCTGACCGAGAGCTGCGAACAGTCAGACAGACGATGATTGACTTCCTGCAGAACCACACGGAAGGAAGCCGGCCCCCTGCCTGCCCGCGCCTAGACCCCATTCAGCCCAGTGATGTTCTTTCCCTTCTTGACAACCGTGGCAGCCATTACGTGGCTATTGTCTTTGAAAGCAACAGCTCCTACCTTGGACGGGAGGTGATCTTAGACCTGATCCCGTATGAAAGCATCGTGGTGACCCGAGCACTGGACGGGGACAAAGCATTTCTGGAGAAACTTGGTGTTTCTTCAGTCCCTTCGTGTTACCTGATCTACCCAAATGGGTCGCATGGATTGATTAACGTCGTGAAGCCTCTGCGGGCCTTCTTTTCGTCTTATTTGAAGTCATTGCCGGATGTGAGGAAAAAATCGCTTCCCTTGCCTGAAAAGCCACACAAAGAAGAAAATTCAGAAATCGTGGTTTGGAGAGAATTTGACAAGTCGAAGCTGTACACGGTGGACCTGGAGTCAGGGCTACACTACCTCCTGCGGGTGGAGCTGGCAGCCCACAAGTCCCTGGCCGGAGCAGAGCTGAAGACGCTCAAGGACTTTGTGACTGTCTTGGCCAAGCTGTTCCCTGGACGGCCGCCAGTCAAGAAGCTGTTGGAGATGCTGCAGGAGTGGCTGGCCAGCCTTCCCCTGGACAGGATCCCCTACAACGCCGTGCTTGACCTGGTCAACAACAAGATGCGGATTTCTGGAATATTCCTTACTAATCACATAAAGTGGGTTGGATGTCAAGGAAGCCGATCTGAGTTGAGGGGTTACCCGTGTTCTCTCTGGAAACTGTTCCACACTTTGACTGTTGAAGCCTCGACCCACCCAGATGCACTGGTTGGCACAGGCTTTGAAGACGACCCCCAGGCTGTGCTGCAGACAATGAGGAGGTACGTTCACACCTTCTTTGGGTGTAAGGAATGTGGTGAGCACTTTGAGGAAATGGCTAAAGAATCCATGGACTCGGTGAAAACCCCAGACCAAGCCATCCTCTGGCTGTGGAAGAAGCATAATATGGTGAACGGCCGCCTGGCAGGCCATCTGAGTGAGGATCCCCGGTTTCCAAAGCTTCAGTGGCCCACTCCGGACCTCTGCCCAGCCTGCCATGAGGAAATTAAGGGCCTGGCCAGCTGGGATGAAGGCCACGTGCTCACATTCTTGAAGCAGCACTATGGCCGCGACAACCTCTTAGACACGTATTCCGCAGACCAGGGGGATTCCAGTGAAGGAGGAACCCTGGCCAGGGGTGAGGAAGAGGAGAAAAGACTCACTCCCCCAGAGGTGTCCCATGGAGACCGAGACACCCAGAGCGTCCGTCCACCTGGTGCACTGGGCCCCAGGCCTGCCCTTCCAGAGAGCTTGCATCACAGCTTGGACGGGAAACTCCAGAGTCTGGATGGGCCCGGGGCCCACAAGGAGGTGGGCGGGGCCGCACCCTTCCTCGGGGTTGACTTCTCCAGCCTGGACATGAGTCTCTGTGTCGTGCTGTACGTGGCTTCATCCCTGTTCCTCATGGTGATGTACTTCTTCTTCCGGGTGAGGTCCAGGCGGTGGAAGGTCAAGCACCACCACCCGGCCGTGTGA
ORF Protein Sequence MAAAGAAVARSPGIGAGPALRARRSPPPRAARLPRLLVLLAAAAVGPGAGGAARLYRAGEDAVWVLDSGSVRGATANSSAAWLVQFYSSWCGHCIGYAPTWRALAGDVRDWASAIRVAALDCMEEKNQAVCHDYDIHFYPTFRYFKAFTKEFTTGENFKGPDRELRTVRQTMIDFLQNHTEGSRPPACPRLDPIQPSDVLSLLDNRGSHYVAIVFESNSSYLGREVILDLIPYESIVVTRALDGDKAFLEKLGVSSVPSCYLIYPNGSHGLINVVKPLRAFFSSYLKSLPDVRKKSLPLPEKPHKEENSEIVVWREFDKSKLYTVDLESGLHYLLRVELAAHKSLAGAELKTLKDFVTVLAKLFPGRPPVKKLLEMLQEWLASLPLDRIPYNAVLDLVNNKMRISGIFLTNHIKWVGCQGSRSELRGYPCSLWKLFHTLTVEASTHPDALVGTGFEDDPQAVLQTMRRYVHTFFGCKECGEHFEEMAKESMDSVKTPDQAILWLWKKHNMVNGRLAGHLSEDPRFPKLQWPTPDLCPACHEEIKGLASWDEGHVLTFLKQHYGRDNLLDTYSADQGDSSEGGTLARGEEEEKRLTPPEVSHGDRDTQSVRPPGALGPRPALPESLHHSLDGKLQSLDGPGAHKEVGGAAPFLGVDFSSLDMSLCVVLYVASSLFLMVMYFFFRVRSRRWKVKHHHPAV

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-MP1443-Ab Anti-QSOX2/ QSCN6L1/ SOXN monoclonal antibody
    Target Antigen GM-Tg-g-MP1443-Ag QSOX2 VLP (virus-like particle)
    ORF Viral Vector pGMLV001675 Human QSOX2 Lentivirus plasmid
    ORF Viral Vector vGMLV001675 Human QSOX2 Lentivirus particle


    Target information

    Target ID GM-MP1443
    Target Name QSOX2
    Gene Group Identifier
    （Target Gene ID in Homo species)         		169714
    Gene ID 101092406 (Felis catus), 102147928 (Equus caballus), 169714 (Homo sapiens), 227638 (Mus musculus)
    607571 (Canis lupus familiaris), 681023 (Rattus norvegicus), 721768 (Macaca mulatta), 788063 (Bos taurus)
    Gene Symbols & Synonyms QSOX2,Qsox2,SOXN,QSCN6L1,Soxn,Qscn6l1
    Target Alternative Names Neuroblastoma-derived sulfhydryl oxidase,QSCN6L1,QSOX2,Qscn6l1,Qsox2,Quiescin Q6-like protein 1,SOXN,Soxn,Sulfhydryl oxidase 2
    Uniprot Accession Q3TMX7,Q6ZRP7
    Additional SwissProt Accessions: Q6ZRP7,Q3TMX7
    Uniprot Entry Name
    Protein Sub-location Transmembrane Protein
    Category
    Disease
    Disease from KEGG
    Gene Ensembl ENSECAG00000020761, ENSG00000165661, ENSMUSG00000036327, ENSCAFG00845006815, ENSMMUG00000004885, ENSBTAG00000011129
    Target Classification


    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.